New Mexico reaches $19M deal with drug maker

SANTA FE, N.M. (AP) — New Mexico Attorney General Gary King says the state has reached a multimillion-dollar settlement with a manufacturer over alleged misrepresentations regarding a diabetes drug.

King announced Monday that New Mexico should net close to $19 million from the deal.

Prosecutors alleged that GlaxoSmithKline downplayed or misrepresented the risk of cardiovascular disease associated with the use of Avandia.

King says the settlement returns about $15 million related to consumer claims and about $3.8 million to offset Medicaid expenditures on the drug. provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language, racial slurs or consistent name calling will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review.

blog comments powered by Disqus